Alk-Abello (4AJ0.F) Stock Highlights

20.56 | -2.93%

2024-12-21 02:18:04

Alk-Abello A/S is a biotechnology company that focuses on pharmaceutical prevention, diagnosis, and treatment of allergies. The company is focused on respiratory diseases, including allergic rhinitis and allergic asthma. Moreover, the firm specializes in venom immunotherapy for patients suffering from bee and wasp allergies. The companys treatments induce a protective immune response that provides sustained symptom relief. Its primary focus is on allergy patients whose disease is not well controlled, despite the use of symptom-relieving medication.

Statistics

Range Today

20.56 20.56

Volume Today 150

Range 1 Year

13.1 24.56

Volume 1 Year 30.32K

Range 3 Year

9.36 24.56

Volume 3 Year 79.14K

Range 10 Year

4.35 24.56

Volume 10 Year 324.24K

Highlights

Market Capitalization 4.87B (mid)

Floating Shares 131.36M

Current Price 20.56

Price To Earnings 47.67

Price To Revenue 0.91

Price To Book 0.93

Earnings Per Share 0.43

Payout Ratio 0%

Performance

Latest -2.93%

1 Month 0%

3 Months -14.69%

6 Months +6.03%

1 Year +56.71%

3 Years -7.8%

5 Years +87.08%

10 Years +362.02%

Benchmarks

Market Capitalization

0 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

0 / 368

Free Cashflow

0 / 352

Performance 5 years

0 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.